Velocity’s research site in Binghamton partners with United Health Services (UHS) to conduct clinical trials for a broad range of investigational treatments. Research studies at this site explore vaccines and medicines developed to treat migraines, diabetes, acne, depression, high cholesterol, and other conditions. All trials conducted at the site are performed in accordance with ICH and FDA guidelines, and in compliance with GCP. Acquired by Velocity in 2022, the Binghamton location conducted clinical trials for years, first with Regional Clinical Research, then as part of Meridian Clinical Research.
Through the partnership with UHS, the site is easily accessible to thousands of patients, including those established with the practice. Our Binghamton team is committed to being a resource for study participants, to providing the highest quality of patient care with compassion and kindness, and to advancing medicine through research.